Search

Author/Creator Bunck, Anne

1. Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma. (July 2019)

Authors:
Riedel, Richard; Michels, Sebastian; Heydt, Carina; Siemanowski, Janna; Kobe, Carsten; Bunck, Anne; Schäfer, Stephan; Fischer, Rieke N.; Scheffler, Matthias; Abdulla, Diana S.Y.; Nogová, Lucia; Koleczko, Sophia; Merkelbach-Bruse, Sabine; Büttner, Reinhard; Wolf, Jürgen
Journal:
Lung cancer
Issue:
Volume 133(2019)
Page Start:
20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors. (January 2023)

Authors:
Riedel, Richard; Fassunke, Jana; Tumbrink, Hannah L.; Scheel, Andreas H.; Heydt, Carina; Hieggelke, Lena; Scheffler, Matthias; Heimsoeth, Alena; Nogova, Lucia; Michels, Sebastian; Weber, Jan-Phillip; Fischer, Rieke N.; Eisert, Anna; Westphal, Theresa; Schaufler, Diana; Siemanowski, Janna; Ihle, M...
Journal:
European journal of cancer
Issue:
Volume 179(2023)
Page Start:
124
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search